The Board of Directors has general responsibility for the Company’s governance and the appropriate organization of operations. The Board of Directors affirms the principles of the Company’s strategy, organization, accounting and controlling the management of assets, and appoints the CEO of the Company. The CEO is responsible for carrying out the strategy of the Company and for day-to-day administration based on the instructions and orders issued by the Board of Directors.
Anna Tenstam
Chairman of the Board and Independent board member
Board member since: 2021
Education: MSc, Uppsala University, Sweden. MBA, IMD Lausanne, Switzerland.
About: Anna Tenstam has over 30 years of leadership experience in pharmaceutical, medical devices and medical aesthetics companies worldwide. She has held executive positions in several global companies in these industries, as well as managed global brands and has been involved in several exits with companies such as Medicis, J&J, and Galderma. Tenstam built and managed global and local distribution networks via branches and distribution partners. She has served as Sr Advisor and fundraising executive for pharma and medical devices companies. Tenstam is the national project lead for Female Health Network and a member of Pokerface business network with entrepreneurs in Sweden. Lately she has been prioritizing a mentoring role to aspiring business people who are looking to enter the medical industry, and coaching young entrepreneurs in Sweden.
No. of shares in Medicortex/shareholding: 7000
Independence: Independent member
Dr. Adrian Harel
CEO, Founder of Medicortex, Dependent board member
Board member since: 2014
Education: PhD Neurobiology, Weizmann Institute of Science, Israel. Post Doctorate, Washington University School of Medicine and Searle, St. Louis Missouri. MBA Business Administration, University of Haifa, Israel.
About: Dr. Harel has many years of experience in the pharmaceutical and biotech industry, and extensive Drug R&D know-how as well as GMP production and manufacturing knowledge. He combines a broad scientific education with extensive industry experience. He has had several management positions, e.g., he was the CEO of ProNeuron where he was the head of a research division which had more than 20 scientists divided into three teams of research in different aspects including cell therapy, drug development and basic research. Additionally, in his last position, before Medicortex, he was the CEO of BrainStorm Cell Therapeutics (BCLI), a publicly-traded company in New York.
No. of shares in Medicortex/shareholding: 9 435 650
Independence: Dependent member
Nils Grönberg
Independent board member
Board member since: 2024
About: Nils Grönberg has over 30 years of experience in leadership. He has held executive positions in several bigger and smaller foundations and companies in Turku area in Finland. In addition, Grönberg has expertise in sales management, cooperative networking, investing, and fundraising.
No. of shares in Medicortex/shareholding: 0
Independence: Independent member
Ville Ranta-Panula
Independent board member
Board member since: 2024
Education: MSc in Drug Development, University of Turku, Finland. MBA, University of Turku, Finland.
About: Ville Ranta-Panula is an experienced and globally networked drug and business development professional with a demonstrated history of working in the pharmaceuticals industry. His current position is Chief Commercial Officer at CRST Oy. Ranta-Panula holds a Certified Board Member certificate and is a board member of Turun Hallituspartnerit ry. He has expertise in budgeting, business strategy, clinical trials, and sales.
No. of shares in Medicortex/shareholding: 0
Independence: Independent member